300482 萬孚生物
按盤價 
23.110 +0.100 (+0.435%)
23.110 +0.100 (+0.435%) | 2025/06 - 中期 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 3.407 | 11.154 | 11.007 | 31.105 | 20.481 |
| 總資產報酬率 ROA (%) | 2.692 | 8.690 | 8.078 | 21.458 | 13.849 |
| 投入資產回報率 ROIC (%) | 3.019 | 9.745 | 9.139 | 25.310 | 16.723 | 邊際利潤分析 |
| 銷售毛利率 (%) | 62.867 | 64.145 | 62.611 | 51.824 | 58.463 |
| 營業利潤率 (%) | 16.685 | 20.779 | 19.861 | 24.078 | 20.586 |
| 息稅前利潤/營業總收入 (%) | 17.779 | 20.611 | 19.326 | 24.009 | 21.702 |
| 淨利潤/營業總收入 (%) | 15.270 | 18.442 | 17.629 | 20.951 | 18.821 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 86.168 | 100.220 | 86.963 | 98.971 | 88.859 |
| 價值變動淨收益/利潤總額(%) | 13.245 | 5.010 | 8.488 | 5.319 | 8.526 |
| 營業外收支淨額/利潤總額(%) | -1.497 | -1.173 | -1.549 | -0.235 | -1.677 | 償債能力分析 |
| 流動比率 (X) | 5.717 | 4.609 | 6.677 | 2.936 | 3.266 |
| 速動比率 (X) | 5.130 | 4.171 | 5.952 | 2.586 | 2.778 |
| 資產負債率 (%) | 18.444 | 21.026 | 20.048 | 27.988 | 27.838 |
| 帶息債務/全部投入資本 (%) | 9.813 | 9.666 | 11.762 | 18.144 | 15.825 |
| 股東權益/帶息債務 (%) | 903.397 | 916.117 | 730.796 | 441.986 | 524.162 |
| 股東權益/負債合計 (%) | 436.218 | 369.218 | 390.286 | 246.313 | 248.056 |
| 利息保障倍數 (X) | 13.271 | 284.607 | -83.428 | -1,954.013 | 14.910 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 166.543 | 100.648 | 74.110 | 32.907 | 41.111 |
| 存貨周轉天數 (天) | 137.547 | 116.457 | 130.828 | 51.713 | 98.364 |
| 備註： | 報價延遲最少15分鐘，資料更新時間為 22/08/2025 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
